Quick Takeaways
- Hudson Bay Capital Management LP filed SCHEDULE 13G/A for Psyence Biomedical Ltd. Common Shares, no par value (PBM).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2024.
Hudson Bay Capital Management LP - 31 Dec 2024 SCHEDULE 13G/A Report for Psyence Biomedical Ltd. Common Shares, no par value (PBM)
- Filing Manager
- Hudson Bay Capital Management LP
- Reporting Manager
- Hudson Bay Capital Management LP
- Symbol
- PBM
- Shares outstanding
- 3,807,615 shares
- Disclosed Ownership
- 380,000 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Feb 2025, 20:00:10 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 14 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Hudson Bay Capital Management LP disclosed 10% ownership in Psyence Biomedical Ltd. Common Shares, no par value (PBM) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2025, 20:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 10% | 380,000 | 0 | 380,000 | /s/ Sander Gerber | Sander Gerber, Authorized Signatory | |
| Sander Gerber | 10% | 380,000 | 0 | 380,000 | /s/ Sander Gerber | Sander Gerber, Individually |